Inga Back, MPH

MPH

All articles by Inga Back, MPH

coronavirus infection in lungs, COVID-19

Rituximab Associated With More Severe COVID-19 in Patients With Inflammatory Rheumatic and Musculoskeletal Diseases

Inga Back, MPH

May 18, 2021

Researchers investigated the association between rituximab and severe COVID-19 outcomes in patients with inflammatory rheumatic and musculoskeletal diseases.

COVID19

ACR Releases COVID-19 Vaccine Clinical Guidance for Patients With Rheumatic and Musculoskeletal Diseases

Inga Back, MPH

March 5, 2021

The American College of Rheumatology developed clinical guidance for the use of COVID-19 vaccines in patients with rheumatic and musculoskeletal diseases.

Next post in COVID19

Inga Back, MPH

All articles by Inga Back, MPH

Rituximab Associated With More Severe COVID-19 in Patients With Inflammatory Rheumatic and Musculoskeletal Diseases

ACR Releases COVID-19 Vaccine Clinical Guidance for Patients With Rheumatic and Musculoskeletal Diseases

Clinical Outcomes of Women With and Without COVID-19 Giving Birth